Tovorafenib and its Impurities

Tovorafenib, known as Ojemda, is an oral, selective type II RAF kinase inhibitor for treating children aged 6 months and older with relapsed or refractory pediatric low-grade glioma (pLGG) having a BRAF fusion, rearrangement, or V600E mutation. Reference standards of Tovorafenib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 4 results for Tovorafenib Impurities
PA 20 4120000

Tovorafenib

Tovorafenib

  • Catalogue No.:PA 20 4120000

  • CAS :

    1096708-71-2

  • Molecular Formula : C17H12Cl2F3N7O2S

  • Molecular Weight : 506.29

Enquire
Details
PA 20 4121000

(R)-2-(1-Aminoethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide

(R)-2-(1-Aminoethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide

  • Catalogue No.:PA 20 4121000

  • CAS :

    1095823-62-3

  • Molecular Formula : C12H10ClF3N4OS

  • Molecular Weight : 350.74

Enquire
Details
PA 20 4121001

6-Amino-5-chloropyrimidine-4-carboxylic Acid

6-Amino-5-chloropyrimidine-4-carboxylic Acid

  • Catalogue No.:PA 20 4121001

  • CAS :

    914916-98-6

  • Molecular Formula : C5H4ClN3O2

  • Molecular Weight : 173.56

Enquire
Details
PA 20 4121002

S-Tovorafenib

S-Tovorafenib

  • Catalogue No.:PA 20 4121002

  • CAS :

    1096708-73-4

  • Molecular Formula : C17H12Cl2F3N7O2S

  • Molecular Weight : 506.29

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help